A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
מצבים רפואיים
Immunoglobulin A Nephropathy (IgAN)
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Colorado Kidney Care Nephrology, Denver, Colorado, United States
Contact: Principal Investigator (Laura Kooienga)American Clinical Trials, Acworth, Georgia, United States
Contact: Principal Investigator (Chinedu Nweke)Univ Of Iowa Hospitals And Clinics, Iowa City, Iowa, United States
Contact: Study coordinator (Christine Zabawa) · christine-zabawa-hamilton@uiowa.edu · +1 319 356 1826Contact: Principal Investigator (Lama Noureddine)Inter Med Consultants, Edina, Minnesota, United States
Contact: Principal Investigator (Jonathan Tolins)Novartis Investigative Site, Serra, Espírito Santo, Brazil
Novartis Investigative Site, Botucatu, São Paulo, Brazil
Novartis Investigative Site, Beijing, China
Novartis Investigative Site, Shanghai, China
Novartis Investigative Site, Munich, Bavaria, Germany
Novartis Investigative Site, Hanover, Germany
Novartis Investigative Site, Mainz, Germany
Novartis Investigative Site, Ranica, BG, Italy
Novartis Investigative Site, Brescia, BS, Italy
Novartis Investigative Site, Pavia, PV, Italy
Novartis Investigative Site, Kawasaki, Kanagawa, Japan
Novartis Investigative Site, Miyazaki, Japan
Novartis Investigative Site, Lodz, Poland
Novartis Investigative Site, Opole, Poland
Novartis Investigative Site, Seoul, Seoul, South Korea
Novartis Investigative Site, Seoul, South Korea
Novartis Investigative Site, Pamplona, Navarre, Spain
Novartis Investigative Site, Valencia, Valencia, Spain
Novartis Investigative Site, Barcelona, Spain
Novartis Investigative Site, Seville, Spain
Novartis Investigative Site, Kaohsiung City, Taiwan
Novartis Investigative Site, Taipei, Taiwan
מובילי המחקר
Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals